Topamax Birth Defects
Women taking Topamax (generic: Topiramate) during pregnancy have an increased risk of delivering a child with an oral birth defect, according to the FDA. Data found that the risk of oral birth defects is up to 16 times greater in women who took Topamax or topiramate during pregnancy. Due to the increased risk of Topamax birth defects, women who took the drug during pregnancy and delivered a child with a cleft palate or cleft lip may have legal recourse.
If you delivered a child with a Topamax birth defect, you may be entitled to compensation for medical bills and other damages. Fill out our free case evaluation form on the right with details of your Topamax birth defect claim to find out if you have legal recourse.
Topamax Birth Defects: Cleft Palates and Lips
Data regarding Topamax birth defects found that 1.4% of infants exposed to Topamax during pregnancy were born with an oral birth defect. This percentage is compared to an oral birth defect rate of .38% to .55% among infants exposed to other seizure medications during pregnancy and .07% among children not exposed to epilepsy drugs.
Topamax birth defects, which result from the drug’s usage during pregnancy, are a type of facial and oral malformation that occurs during the first trimester. Cleft palates and cleft lips typically develop when there is not enough tissue present in the mouth or lip area, and the tissue that is available does not fuse together correctly. These Topamax birth defects can be further explained below:
Topamax Cleft Lip: A cleft lip is a physical separation or split of the two sides of the upper lip. This oral birth defect is typically seen as a gap in the skin or narrow opening of the upper lip. This split may extend beyond the base of the nose.
Topamax Cleft Palate: A cleft palate is an opening or split in the palate (roof of the mouth). This oral birth defect can affect the hard palate or the soft palate, and may occur alone or alongside a cleft lip.
Did you deliver a child with a cleft lip or cleft palate after taking Topamax during pregnancy? If so, complete our free case review form to find out if you are entitled to financial compensation.
Topamax and Pregnancy
Due to the risk of topiramate birth defects, the FDA has decided to make changes to the drug’s label and pregnancy classification. Topamax was previously classified as a Pregnancy category C drug, meaning that results from animal research found that the drug could potentially harm a fetus, but data from human studies was not available at the time of approval. Now, the seizure and migraine medication will be classified in Pregnancy Category D, which means there is positive evidence of fetal risk based on human data, but the potential benefits of the drug’s use in pregnant women may still be acceptable in some cases.
Due to the FDA’s announcement of the Topamax birth defect risk, women who delivered children with cleft palates or cleft lips after taking the drug during pregnancy may have legal recourse. Topamax birth defects can necessitate costly surgeries and procedures, and these expenses are among the damages which may be available to women who elect to take legal action. To find out if you can participate in a Topamax lawsuit, complete our no cost, no obligation case review form today.